Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday. Activision Blizzard Inc. (NASDAQ: ATVI) raised to Overweight at Piper Jaffray. Arena…
The history of weight loss drugs is sketchy at best. But VIVUS Inc. (NASDAQ: VVUS) is making up on all of its recent losses, after shares slid from almost $30 to just…
The Dow Jones Industrial Average, Nasdaq and S&P 500 are all down more than 1% Thursday morning, with banks and health insurance stocks down the most in the broader market. Nevertheless, the big winners and…
247sam Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday. Anadarko Petroleum Corporation (NYSE: APC) Raised to Outperform at Bernstein. Apple Inc.…
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company’s weight-loss drug called BELVIQ has been approved. The news is good for all obesity drug makers today. VIVUS Inc.…
We are tracking and analyzing a significant volume spike in shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today. Shares are up nearly 5% at $8.25 and the 12:30 PM trading volume is…
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and deleted from them as money management firms often buy and sell shares,…
The major US stock indexes opened significantly lower this morning as investors reacted to the surprise loss of $2 billion by JPMorgan Chase & Co. (NYSE: JPM) disclosed by the bank’s CEO…
VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some caution for…
Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) announced that its application to sell its lorcaserin weight-loss drug in Europe has been accepted by the Europe Medicines Agency. This is the first step…
VIVUS, Inc. (NASDAQ: VVUS) is literally killing short sellers this morning after scoring an FDA panel backing with the recommendation to approve Qnexa as a treatment against obesity. This will likely be an…
VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday. The FDA panel reviewing its Qnexa drug to treat obesity has voted overwhelmingly to offer FDA panel backing in favor…
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and  moves in shares of Adobe Systems Incorporated (NASDAQ: ADBE), Oracle Corporation (NASDAQ: ORCL), and Orexigen Therapeutics…
Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Autodesk, Inc. (NASDAQ: ADSK) Raised to Overweight at JPMorgan. Dollar…
VIVUS, Inc. (NASDAQ: VVUS) is in the news this morning after entering into an agreements with a select group of institutional investors to sell 6,889,098 shares of its common stock. Rather than…
